ArticleFrontiers in immunology2026

3'-hydroxypuerarin mitigates LPS-induced acute lung injury by inhibiting TLR4 activation-mediated NF-κB p65/NLRP3/GSDMD signaling.

Huiyu Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.